Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
about
Clinical impact of five large-scale screening projects for chronic hepatitis B in Chinese migrants in the Netherlands.New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.Oral antiviral therapy reduces the risk of hepatocellular carcinoma in persons with chronic hepatitis B infection: combining evidence and common sense.
P2860
Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Risk prediction of hepatitis B ...... n the era of antiviral therapy
@ast
Risk prediction of hepatitis B ...... n the era of antiviral therapy
@en
Risk prediction of hepatitis B ...... n the era of antiviral therapy
@nl
type
label
Risk prediction of hepatitis B ...... n the era of antiviral therapy
@ast
Risk prediction of hepatitis B ...... n the era of antiviral therapy
@en
Risk prediction of hepatitis B ...... n the era of antiviral therapy
@nl
prefLabel
Risk prediction of hepatitis B ...... n the era of antiviral therapy
@ast
Risk prediction of hepatitis B ...... n the era of antiviral therapy
@en
Risk prediction of hepatitis B ...... n the era of antiviral therapy
@nl
P2860
P356
P1476
Risk prediction of hepatitis B ...... n the era of antiviral therapy
@en
P2093
Il Han Song
P2860
P304
P356
10.3748/WJG.V19.I47.8867
P407
P577
2013-12-21T00:00:00Z